Fax: 415/514-8150.
1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
Epidemiology
You have full text access to this OnlineOpen article
Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients
Article first published online: 9 OCT 2008
DOI: 10.1002/ijc.24054
Copyright © 2008 Wiley-Liss, Inc.
Additional Information
How to Cite
Braithwaite, D., Tammemagi, C. M., Moore, D. H., Ozanne, E. M., Hiatt, R. A., Belkora, J., West, D. W., Satariano, W. A., Liebman, M. and Esserman, L. (2009), Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int. J. Cancer, 124: 1213–1219. doi: 10.1002/ijc.24054
Publication History
- Issue published online: 18 DEC 2008
- Article first published online: 9 OCT 2008
- Accepted manuscript online: 9 OCT 2008 12:00AM EST
- Manuscript Accepted: 10 SEP 2008
- Manuscript Received: 29 MAY 2008
Funded by
- US Department of Defense (Center of Excellence in Breast Cancer Care). Grant Number: DAMD17-03-1-0481
- Kaiser Permanente Community Services Program and the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute. Grant Number: N01-CN-05224
- Windber Research Institute
References
- 1,,,. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 2002; 76: 27–36.
- 2,,,,,. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 2006; 24: 1342–9.
- 3,,. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002; 94: 490–6.
- 4,,,,,,,,,. Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute Black/White Cancer Survival Study experience. Cancer 1992; 70: 2460–7.Direct Link:
- 5,,,,. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005; 294: 1765–72.
- 6,. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974; 27: 387–404.
- 7,,,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83.
- 8. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000; 35: 181–200.
- 9,,,. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 2001; 19: 1147–51.
- 10,,,. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003; 56: 221–9.
- 11,,,. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245–51.
- 12,,,. Impact of comorbidity on lung cancer survival. Int J Cancer 2003; 103: 792–802.Direct Link:
- 13,,,,. High blood-pressure: a risk factor for cancer mortality? Lancet 1975; 1: 1051–6.
- 14,,,. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol 1996; 6: 413–9.
- 15. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992; 82: 703–10.
- 16,. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120: 104–10.
- 17
- 18. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79: 340–9.
- 19,,. Hypertension and breast cancer: an association revisited? J Hum Hypertens 2006; 20: 722–4.
- 20Increased intracellular calcium: from hypertension to cancer. J Hypertens 1987; 5: S3–4.
- 21,,,,,. Letter: hypertension related to DNA repair synthesis and carcinogen uptake. Lancet 1975; 2: 1094.
- 22. Cancer and hypertension. An unresolved issue. Hypertension 1996; 28: 321–4.
- 23
- 24,,,,,. Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol A Biol Sci Med Sci 1998; 53: M372–8.
- 25,,,,. Using administrative data to describe casemix: a comparison with the medical record. J Clin Epidemiol 1994; 47: 1027–32.
- 26,,,,,,. Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 2004; 90: 2332–7.